chronic obstructive pulmonary disease
Conditions
Interventions
Six symptoms groups:Based on the compound Caoshi Silkworm Granule, plus different Chinese medicines
Sponsors
Jinhua Municipal Central Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Choose outpatient, community and discharged patients aged 40-80 years, including Smokers and non-smokers; 2. COPD of stage II-III was clinically diagnosed. The predicted value of FEV1 ranges from 30% to 70% after bronchodilator administration. 3. There were at least two times of acute exacerbation in the first two years of admission. 4. Clinical stability was observed within 2 weeks before admission. 5. Provide written informed consent and be able to fulfill research requirements
Exclusion criteria
Exclusion criteria: 1. Patients with bronchial asthma, cystic fibrosis, active pulmonary tuberculosis, pneumonia, Bronchopneumonia, bronchiectasis, lung cancer, lung metastases and other progressive fatal diseases, 2. Severe cardiovascular disease, severe neurological disease and severe liver function damage or kidney impairment; 3. Patients with poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL-17; | — |
Countries
China
Contacts
Public ContactChen Hui
Jinhua Municipal Central Hospital
Outcome results
None listed